You are here
Continuing Education Credit
The Escalating Role of Epidermal Growth Factor Receptor Inhibitors in Cancer Management
Clinical Considerations for the Health System Pharmacist
Targeted therapies are improving outcomes in patients with colorectal, non–small-cell lung cancer, and pancreatic cancer. The authors evaluate the efficacy of these agents and suggest strategies for preventing and managing adverse effects from these treatments to ensure optimal patient care.